Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/QCO.0000000000000710 http://scihub22266oqcxt.onion/10.1097/QCO.0000000000000710 33492003!ä!33492003 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Opin+Infect+Dis 2021 ; 34 (2): 175-179 Nephropedia Template TP {{tp|p=33492003|t=2021. Applying the lessons learned from coronavirus disease 2019 to improve pneumonia management |pdf=|usr=}}{{33492003}} gab.com Text Applying the lessons learned from coronavirus disease 2019 to improve pneumonia management JO: Curr Opin Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=33492003 #FOAvip PURPOSE OF REVIEW: Coronavirus disease 2019 (COVID-19) has produced an extraordinary amount of literature in a short time period. This review focuses on what the new literature has provided in terms of more general information about the management of community-acquired pneumonia (CAP). RECENT FINDINGS: Measures taken to reduce the spread of COVID-19 have caused a significant drop in influenza worldwide. Improvements in imaging, especially ultrasound, and especially in the application of rapid molecular diagnosis are likely to have significant impact on the management of CAP. Therapeutic advances are so far limited. SUMMARY: COVID-19 has taught us that we can do far more to prevent seasonal influenza and its associated mortality, morbidity and economic cost. Improvements in imaging and pathogen diagnosis are welcome, as is the potential for secondary benefits of anti-COVID-19 therapies that may have reach effect on respiratory viruses other than severe acute respiratory syndrome coronavirus 2. As community-transmission is likely to persist for many years, recognition and treatment of severe acute respiratory syndrome coronavirus 2 will need to be incorporated into CAP guidelines moving forward. Twit Text FOAVip Applying the lessons learned from coronavirus disease 2019 to improve pneumonia management ????Curr Opin Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=33492003 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33492003 #FOAvip English Wikipedia <ref>{{Cite pmid|33492003}}</ref> Applying the lessons learned from coronavirus disease 2019 to improve pneumonia management #MMPMID33492003 Waterer GW Curr Opin Infect Dis 2021[Apr]; 34 (2): 175-179 PMID33492003show ga PURPOSE OF REVIEW: Coronavirus disease 2019 (COVID-19) has produced an extraordinary amount of literature in a short time period. This review focuses on what the new literature has provided in terms of more general information about the management of community-acquired pneumonia (CAP). RECENT FINDINGS: Measures taken to reduce the spread of COVID-19 have caused a significant drop in influenza worldwide. Improvements in imaging, especially ultrasound, and especially in the application of rapid molecular diagnosis are likely to have significant impact on the management of CAP. Therapeutic advances are so far limited. SUMMARY: COVID-19 has taught us that we can do far more to prevent seasonal influenza and its associated mortality, morbidity and economic cost. Improvements in imaging and pathogen diagnosis are welcome, as is the potential for secondary benefits of anti-COVID-19 therapies that may have reach effect on respiratory viruses other than severe acute respiratory syndrome coronavirus 2. As community-transmission is likely to persist for many years, recognition and treatment of severe acute respiratory syndrome coronavirus 2 will need to be incorporated into CAP guidelines moving forward. |COVID-19/*diagnosis/epidemiology/*prevention & control/therapy[MESH] |Clinical Laboratory Techniques[MESH] |Community-Acquired Infections/diagnosis/prevention & control/therapy[MESH] |Diagnostic Imaging[MESH] |Humans[MESH] |Infection Control[MESH] |Pneumonia/diagnosis/prevention & control/therapy[MESH]Applying the lessons learned from coronavirus disease 2019 to improve (epmc).pdf DeepDyve Pubget Overpricing